Five-Year Sustained Response to Nivolumab in Hepatocellular Carcinoma following Serious Immune-Related Hepatitis
This case highlights an unusual and sustained response to nivolumab treatment in HCC, following early treatment discontinuation due to severe hepatotoxicity.
Authors
- M. Sardinha (ORCID: https://orcid.org/0000-0002-0220-538X)
- José Leão Mendes (ORCID: https://orcid.org/0000-0003-2458-1746)
- João Boavida Ferreira
- João Pimentel (ORCID: https://orcid.org/0000-0003-1908-8607)
- Ana Sofia Spencer
- Ricardo da Luz
Institutions
- Unidade Local de Saúde de São José (PT)
- Lusíada University of Lisbon (PT)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- Hospital da Luz (PT)
- Asia Center for Air Pollution Research (JP)
- Hospital de Santa Maria (PT)
Publication Details
- Journal
- GE Portuguese Journal of Gastroenterology
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1159/000543288
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.37